Clinical Trials Logo

Clinical Trial Summary

The optimal fluid regimen, haemodynamic (or other) targets and fluid choice (colloid or crystalloid) for patients undergoing major surgery are based on rationales that are not supported by strong evidence. Practices vary substantially, guidelines are vague, small trials and meta-analyses are contradictory. The strongest and most consistent evidence, and biological plausibility because of tissue edema, supports a restrictive fluid strategy. But other evidence supports goal-directed therapy, requiring additional IV fluid. There is no good evidence that use and choice of colloids improves outcome. RELIEF will study the effects of fluid restriction, and the possible effect-modification of goal-directed therapy and colloids. The first will be randomly assigned; the latter will be measured covariates dictated by local practices and beliefs.

Study Hypotheses A restrictive fluid regimen for adults undergoing major abdominal surgery leads to reduced complications and improved disability-free survival when compared with a liberal fluid regimen.

Secondary hypothesis: The effects of fluid restriction are similar whether or not goal-directed therapy is used (assessed as a statistical test of interaction). A restrictive fluid regimen will reduce a composite of 30-day septic complications and mortality.


Clinical Trial Description

The investigators have completed a pilot study of 82 subjects to test the feasibility of the trial (2011), and are currently doing a cost-effectiveness substudy (2012-13)

1. AIM OF THE TRIAL To investigate the effectiveness of fluid restriction (vs. liberal), and the possible effect-modification of goal-directed therapy (eg. oesophageal Doppler, Flotrac®). The first will be randomly assigned; the latter will be measured covariates according to local practices and beliefs.

The optimal fluid regimen and haemodynamic (or other) targets for patients undergoing major surgery are based on rationales that are not supported by strong evidence. Practices vary substantially; guidelines are vague, small trials and meta-analyses are contradictory. The strongest and most consistent evidence, and biological plausability regarding tissue oedema, supports a restrictive fluid strategy. There is less (and more contradictory) evidence supporting goal-directed therapy using a flow-directed device and/or dopexamine, and use and choice of colloids. A large, definitive clinical trial evaluating perioperative fluid replacement in major surgery is required.

Study Hypotheses A restrictive fluid regimen for adults undergoing major abdominal surgery leads to reduced complications and improved disability-free survival when compared with a liberal fluid regimen.

Secondary hypotheses: The effects of fluid restriction are similar whether or not goal-directed therapy is used (assessed as a statistical test of interaction). A restrictive fluid regimen will reduce a composite of 30-day septic complications and mortality. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01424150
Study type Interventional
Source Bayside Health
Contact
Status Completed
Phase Phase 4
Start date July 2013
Completion date October 22, 2017

See also
  Status Clinical Trial Phase
Completed NCT01611376 - Impedance Cardiography During Major Abdominal Surgery Phase 4
Recruiting NCT05556174 - Intraoperative Lung Protective Ventilation Needs Periodic Lung Recruitment Maneuvers N/A
Completed NCT03633123 - D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection Phase 2
Terminated NCT03684304 - The Effect of Abdominal Binder Use on Postoperative Pain and Mobility in Patients Undergoing Pelvic Surgery N/A
Active, not recruiting NCT02817893 - Comparison of Respiratory Variations of the Pulse Oximetry Plethysmographic Raw Signal and Pulse Pressure During Abdominal Surgery (PLETHYSMO) N/A
Completed NCT04120740 - Validation of Two Acitivity Monitors in Three Inpatient Populations.
Recruiting NCT03700749 - FALCON Trial Testing Measures to Reduce Surgical Site Infection Phase 3
Completed NCT01389648 - Pre-operative Physiotherapy to Prevent Post-operative Complications N/A
Withdrawn NCT00557843 - Continuous Bupivacaine Infusion Following Colonic Surgery N/A
Active, not recruiting NCT01839617 - Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery N/A
Terminated NCT04887922 - Preoperative and Postoperative Incentive Spirometry in Patients Undergoing Major Abdominal Surgery N/A
Completed NCT04730141 - Effect of Mobilization Protocol on Mobilization N/A
Completed NCT00683150 - Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring N/A
Active, not recruiting NCT03933306 - Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes Phase 4
Recruiting NCT05268432 - Development, Intraoperative Demonstration and Visualization of Surgical Assistance Functions
Not yet recruiting NCT04747535 - Continuous Positive Airway Pressure After Abdominal Surgery N/A
Not yet recruiting NCT05253586 - Versius Or Laparoscopic Abdominal Hernia REpair
Recruiting NCT06374849 - Intraoperative Sufentanil and Chronic Postsurgical Pain in Non-major Scheduled Abdominal Surgery Phase 4
Recruiting NCT05246605 - Postoperative Hypoxia and Body Position N/A
Recruiting NCT04685876 - Comparing TAP Blocks Bupivacaine, and Placebo for Plane Phase 3